Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly
Journal of Bone and Mineral Metabolism · 2025
DOI: 10.1007/s00774-024-01561-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, 2025. Verfasst von Fabiana Freire Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Unit, Center for Diabetes and Endocrinology of Bahia, Salvador, Bahia, Brazil. fabifreire@netscape.net. Hauptthemen laut MEDLINE: Bone Density, Acromegaly, Bone Remodeling, Hypogonadism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The purpose of this study was to evaluate the impact of disease activity and gonadal status on bone mineral density (BMD) and turnover markers (BTMs) in individuals with acromegaly. MATERIALS AND METHODS: Subjects underwent laboratory tests for PTH, 25-hydroxyvitamin D, calcium, phosphorus, osteocalcin (OC) and C-telopeptide (CTX-1) and bone densitometry at the lumbar spine (LS), femoral neck (FN) and total hip (TH). RESULTS: Sixty participants (48.6 ± 11.0 years; 66,7% female) were included in this cross-sectional study. Phosphorus, OC, CTX-1, and LS BMD were greater in the active disease group than in the controlled/cured disease group (P = 0.025, P < 0.001, P = 0.007, and P = 0.016, respectively). When analyzing gonadal status, phosphorus, OC and CTX-1 were greater in the hypogonadal group than in the eugonadal group (P = 0.017, P = 0.015, and P = 0.033, respectively). Patients with hypogonadism had a higher prevalence of reduced bone mass compared to eugonadal patients (44 vs. 17%, P = 0.023). CONCLUSION: This study revealed increased levels of phosphorus and BTMs in patients with active acromegaly. In this group, the greater LS BMD values are likely due to the anabolic effects of GH and IGF-1 and/or to the influence of LS arthropathy. Moreover, hypogonadism negatively impacts bone metabolism in acromegaly, leading to elevated BTMs and a higher prevalence of reduced bone mass in individuals affected by both conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroendocrine Unit, Center for Diabetes and Endocrinology of Bahia, Salvador, Bahia, Brazil. fabifreire@netscape.net.
- Department of Endocrinology, Roberto Santos General Hospital, Salvador, Bahia, Brazil. fabifreire@netscape.net.
- Department of Endocrinology, Roberto Santos General Hospital, Salvador, Bahia, Brazil.
- Department of Postgraduate Education, Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil.
- Neuroendocrine Unit, Center for Diabetes and Endocrinology of Bahia, Salvador, Bahia, Brazil.
Zitieren
APA
Silva, F. F., Lima, M. L., Pedreira, C. C., & Matos, M. A. (2025). Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-024-01561-z
Vancouver
Silva FF, Lima ML, Pedreira CC, Matos MA. Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly. Journal of Bone and Mineral Metabolism. 2025. doi:10.1007/s00774-024-01561-z
BibTeX
@article{Silva2025,
author = {Silva, Fabiana Freire and Lima, Maria de Lourdes and Pedreira, Clarissa Carvalho and Matos, Marcos Almeida},
title = {Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly},
journal = {Journal of Bone and Mineral Metabolism},
year = {2025},
doi = {10.1007/s00774-024-01561-z}
}
EUVIMED